Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 5Recruiting 3Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Breast Neoplasms 11Adenocarcinoma of Lung 4Rectal Neoplasms 3Triple Negative Breast Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Neoplastic Cells, Circulating 1Lymphedema 1Lung Neoplasms 1Carcinoma, Lobular 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Ductal, Breast 1

Interventions

Capecitabine 29Oxaliplatin 28Fluorouracil 16Radiotherapy 15Drug Therapy 11Leucovorin 10Bevacizumab 10Surgical Procedures, Operative 9Chemoradiotherapy 8Radiation 7sintilimab 6Consolidation Chemotherapy 6tislelizumab 5spartalizumab 5Specimen Handling 5Irinotecan 5Folfox protocol 5trifluridine tipiracil drug combination 4XELOX 4Neoadjuvant Therapy 4Endoscopy 4Cetuximab 4Biopsy 4toripalimab 3pembrolizumab 3irinotecan sucrosofate 3X-Rays 3Radiotherapy, Intensity-Modulated 3Proctectomy 3Mastectomy, Segmental 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Rectal Neoplasms × Mastectomy, Segmental × Clear all
NCT06249672 2026-05-05

PRESERVE

Insel Gruppe AG, University Hospital Bern

Recruiting
200 enrolled
Gastrointestinal

Rectal Neoplasms

NCT06209099 2025-06-12

Organ Preservation First Strategy and Intentional Watch and Wait for MRI Defined Low-risk Rectal Cancer

Peking University Cancer Hospital & Institute

Phase NA Recruiting
96 enrolled
Gastrointestinal

Rectal Neoplasms

NCT05772923 2023-03-17

OPAXX

The Netherlands Cancer Institute

Phase NA Recruiting
168 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡